REFERENCES
- Awad SA, Downie JW, Kiruluta HG. Alpha-adrenergic agents in urinary disorders of the proximal urehra. Part II. Urethral obstruction due to “sympathetic dyssynergia”. Br J Urol 1978; 50: 336–339.
- Axelrod SL, Blaivas JG. Bladder neck obstruction in women. J Urol 1987; 137: 497–499.
- Axelrod SL, Regnier C, Blaivas J. Bladder outlet obstruction vs. impaired detrusor contractility. In: Proceedings from the International Continence Society, 16th Annual Meeting, Boston, 1986: 287–289.
- Caine M. The present role of alpha-adrenergic blockers in the treatment of benign prostatic hypertrophy. J Urol 1986; 136: 1–4.
- Eaton AC, Bates CP. An in vitro physiological study of normal and unstable human detrusor muscle. Br J Urol 1982; 54: 653–657.
- Gerstenberg TC, Nielsen ML, Lindenberg J. Spastic striated external sphincter syndrome imitating recurrent urinary tract infection in females. Eur Urol 1983; 9: 87–92.
- Godfrey K. Statistics in practice. N Engl J Med 1985; 313: 1450–1456.
- Gosling JA. The distribution of noradrenergic nerves in the human lower urinary tract. Clin Sci 1986; 70 (Suppl 14): 3s–6s.
- deGroat WC, Booth AM. Physiology of the urinary bladder and urethra. Ann Int Med 1980; 92 (part 2): 312–315.
- Grynderup V. A comparison of some rating systems in multiple sclerosis. Acta Neurol Scand 1969; 45: 611–622.
- Hills M, Armitage P. The two-period cross-over trial. Br J Clin Pharmacol 1979; 8: 7–20.
- Jensen DJr. Uninhibited neurogenic bladder treated with prazosin. Scand J Urol Nephrol 1981; 15: 229–233.
- Krane JK, Olsson CA. Phenoxybenzamine in neurogenic bladder dysfunction. II. Clinical considerations. J Urol 1973; 110: 650–653.
- Nordling J. Alpha-blockers and urethral pressure in neurological patients. Urol Int 1978; 33: 304–309.
- Nordling J. Noradrenergic innervation of the human bladder in neurogenic dysfunction. Urol Int 1980; 35: 188–193.
- Nordling J, Meyhoff HH, Hald T. Sympatholytic effect on striated urethral sphincter. Scand J Urol Nephrol 1981; 15: 173–180.
- Norlén L, Sundin T. Alpha-adrenolytic treatment in patients with autonomous bladders. Acta Pharmacol Toxicol 1978; 43 (II): 31–34.
- Pedersen E, Petersen T, Schrøder AD. Relation between flexor spasms, uninhibited detrusor contractions and anal sphincter activity. J Neurol Neurosurg Psychiatry 1986; 49: 273–277.
- Pedersen E, Tørring J, Klemar B. Effect of alpha-adrenergic blocking agent thymoxamine on the neurogenic bladder and urethra. Acta Neurol Scand 1980; 61: 107–114.
- Petersen T, Erichsen C. Bladder neck anaesthesia and resection in women with detrusor hyperreflexia. Urol Int 1987; 42: 190–194.
- Petersen T, Jakobsen J. A calcium blocking and anticholinergic agent (terodiline) in the treatment of detrusor hyperreflexia: a placebo-controlled, cross-over trial. J Neurol Neurosurg Psychiatry 1987; 50: 1331–1336.
- Ramsay JWA, Scott GI, Whitfield HN. A double-blind controlled trial of a new alpha-1 blocking drug in the treatment of bladder outlet obstruction. Br J Urol 1985; 57: 657–659.
- Seideman P, Bertilsson L, Haglund K, Sjøqvist F, Tybring G, Østman J. Monoamine metabolites in cerebrospinal fluid during treatment of hypertension with prazosin. Eur J Clin Pharmacol 1980; 18: 399–401.
- Snedecor GW, Cochran WG, eds. Statistical methods. 7th ed. Ames, Iowa, USA: The Iowa State University Press, 1980: 291–292.
- The standardisation of terminology of lower urinary tract function. Scand J Urol Nephrol, Suppl. 114, 1988.
- Stephenson TP. Urethral dysfunction in upper motor neurone lesions. Clin Sci 1986; 70 (Suppl 14): 59s–62s.
- Vereecken RL, Van Poppel H, Boeckx G, Leruitte A. Longterm alpha-adrenergic-blocking therapy in detrusor-urethra dyssynergia. Eur Urol 1983; 9: 167–169.